These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27021940)

  • 41. Characterization of SETD1A haploinsufficiency in humans and Drosophila defines a novel neurodevelopmental syndrome.
    Kummeling J; Stremmelaar DE; Raun N; Reijnders MRF; Willemsen MH; Ruiterkamp-Versteeg M; Schepens M; Man CCO; Gilissen C; Cho MT; McWalter K; Sinnema M; Wheless JW; Simon MEH; Genetti CA; Casey AM; Terhal PA; van der Smagt JJ; van Gassen KLI; Joset P; Bahr A; Steindl K; Rauch A; Keller E; Raas-Rothschild A; Koolen DA; Agrawal PB; Hoffman TL; Powell-Hamilton NN; Thiffault I; Engleman K; Zhou D; Bodamer O; Hoefele J; Riedhammer KM; Schwaibold EMC; Tasic V; Schubert D; Top D; Pfundt R; Higgs MR; Kramer JM; Kleefstra T
    Mol Psychiatry; 2021 Jun; 26(6):2013-2024. PubMed ID: 32346159
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic architecture of schizophrenia: a review of major advancements.
    Legge SE; Santoro ML; Periyasamy S; Okewole A; Arsalan A; Kowalec K
    Psychol Med; 2021 Oct; 51(13):2168-2177. PubMed ID: 33550997
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expansion of the Genotypic and Phenotypic Spectrum of
    Cordova I; Blesson A; Savatt JM; Sveden A; Mahida S; Hazlett H; Rooney Riggs E; Chopra M;
    Genes (Basel); 2024 Mar; 15(4):. PubMed ID: 38674358
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A clustering of heterozygous missense variants in the crucial chromatin modifier WDR5 defines a new neurodevelopmental disorder.
    Snijders Blok L; Verseput J; Rots D; Venselaar H; Innes AM; Stumpel C; Õunap K; Reinson K; Seaby EG; McKee S; Burton B; Kim K; van Hagen JM; Waisfisz Q; Joset P; Steindl K; Rauch A; Li D; Zackai EH; Sheppard SE; Keena B; Hakonarson H; Roos A; Kohlschmidt N; Cereda A; Iascone M; Rebessi E; Kernohan KD; Campeau PM; Millan F; Taylor JA; Lochmüller H; Higgs MR; Goula A; Bernhard B; Velasco DJ; Schmanski AA; Stark Z; Gallacher L; Pais L; Marcogliese PC; Yamamoto S; Raun N; Jakub TE; Kramer JM; den Hoed J; Fisher SE; Brunner HG; Kleefstra T
    HGG Adv; 2023 Jan; 4(1):100157. PubMed ID: 36408368
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetics. Genetic control of hotspots.
    Cheung VG; Sherman SL; Feingold E
    Science; 2010 Feb; 327(5967):791-2. PubMed ID: 20150474
    [No Abstract]   [Full Text] [Related]  

  • 46. Pathogenic SPTBN1 variants cause an autosomal dominant neurodevelopmental syndrome.
    Cousin MA; Creighton BA; Breau KA; Spillmann RC; Torti E; Dontu S; Tripathi S; Ajit D; Edwards RJ; Afriyie S; Bay JC; Harper KM; Beltran AA; Munoz LJ; Falcon Rodriguez L; Stankewich MC; Person RE; Si Y; Normand EA; Blevins A; May AS; Bier L; Aggarwal V; Mancini GMS; van Slegtenhorst MA; Cremer K; Becker J; Engels H; Aretz S; MacKenzie JJ; Brilstra E; van Gassen KLI; van Jaarsveld RH; Oegema R; Parsons GM; Mark P; Helbig I; McKeown SE; Stratton R; Cogne B; Isidor B; Cacheiro P; Smedley D; Firth HV; Bierhals T; Kloth K; Weiss D; Fairley C; Shieh JT; Kritzer A; Jayakar P; Kurtz-Nelson E; Bernier RA; Wang T; Eichler EE; van de Laar IMBH; McConkie-Rosell A; McDonald MT; Kemppainen J; Lanpher BC; Schultz-Rogers LE; Gunderson LB; Pichurin PN; Yoon G; Zech M; Jech R; Winkelmann J; ; ; Beltran AS; Zimmermann MT; Temple B; Moy SS; Klee EW; Tan QK; Lorenzo DN
    Nat Genet; 2021 Jul; 53(7):1006-1021. PubMed ID: 34211179
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of a neurodevelopmental genes based polygenic risk score for schizophrenia and single gene variants on brain structure in non-clinical subjects: A preliminary report.
    Spalthoff R; Degenhardt F; Awasthi S; Heilmann-Heimbach S; Besteher B; Gaser C; Ripke S; Nöthen MM; Nenadić I
    Schizophr Res; 2019 Oct; 212():225-228. PubMed ID: 31395486
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Updating the neurodevelopmental profile of Alazami syndrome: Illustrating the role of developmental assessment in rare genetic disorders.
    Wojcik MH; Linnea K; Stoler JM; Rappaport L
    Am J Med Genet A; 2019 Aug; 179(8):1565-1569. PubMed ID: 31074943
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reduced cortical thickness is associated with the glutamatergic regulatory gene risk variant DAOA Arg30Lys in schizophrenia.
    Schultz CC; Nenadic I; Koch K; Wagner G; Roebel M; Schachtzabel C; Mühleisen TW; Nöthen MM; Cichon S; Deufel T; Kiehntopf M; Rietschel M; Reichenbach JR; Sauer H; Schlösser RG
    Neuropsychopharmacology; 2011 Jul; 36(8):1747-53. PubMed ID: 21508934
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Variants in a noncoding gene drive prevalent neurodevelopmental disorder.
    Whalley K
    Nat Rev Neurosci; 2024 Sep; 25(9):594. PubMed ID: 39075229
    [No Abstract]   [Full Text] [Related]  

  • 51. Loss-of-function of neuroplasticity-related genes confers risk for human neurodevelopmental disorders.
    Smith MR; Glicksberg BS; Li L; Chen R; Morishita H; Dudley JT
    Pac Symp Biocomput; 2018; 23():68-79. PubMed ID: 29218870
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Excess of de novo variants in genes involved in chromatin remodelling in patients with marfanoid habitus and intellectual disability.
    Chevarin M; Duffourd Y; A Barnard R; Moutton S; Lecoquierre F; Daoud F; Kuentz P; Cabret C; Thevenon J; Gautier E; Callier P; St-Onge J; Jouan T; Lacombe D; Delrue MA; Goizet C; Morice-Picard F; Van-Gils J; Munnich A; Lyonnet S; Cormier-Daire V; Baujat G; Holder M; Petit F; Leheup B; Odent S; Jouk PS; Lopez G; Geneviève D; Collignon P; Martin-Coignard D; Jacquette A; Perrin L; Putoux A; Sarrazin E; Amarof K; Missotte I; Coubes C; Jagadeesh S; Lapi E; Demurger F; Goldenberg A; Doco-Fenzy M; Mignot C; Héron D; Jean-Marçais N; Masurel A; El Chehadeh S; Marle N; Huet F; Binquet C; Collod-Beroud G; Arnaud P; Hanna N; Boileau C; Jondeau G; Olaso R; Lechner D; Poe C; Assoum M; Carmignac V; Duplomb L; Tran Mau-Them F; Philippe C; Vitobello A; Bruel AL; Boland A; Deleuze JF; Thauvin-Robinet C; Rivière JB; O'Roak BJ; Faivre L
    J Med Genet; 2020 Jul; 57(7):466-474. PubMed ID: 32277047
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Disrupted intricacy of histone H3K4 methylation in neurodevelopmental disorders.
    Vallianatos CN; Iwase S
    Epigenomics; 2015; 7(3):503-19. PubMed ID: 26077434
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human GRIN2B variants in neurodevelopmental disorders.
    Hu C; Chen W; Myers SJ; Yuan H; Traynelis SF
    J Pharmacol Sci; 2016 Oct; 132(2):115-121. PubMed ID: 27818011
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuregulin 3 is associated with attention deficits in schizophrenia and bipolar disorder.
    Meier S; Strohmaier J; Breuer R; Mattheisen M; Degenhardt F; Mühleisen TW; Schulze TG; Nöthen MM; Cichon S; Rietschel M; Wüst S
    Int J Neuropsychopharmacol; 2013 Apr; 16(3):549-56. PubMed ID: 22831755
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Higher blood MLL1 mRNA and BDNF promoter IV on histone H3K4me3 levels in patients with schizophrenia.
    Huang TL; Lin CC; Chen RF; Lee CT
    Psychiatry Res; 2016 Sep; 243():207-9. PubMed ID: 27419650
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Examining sex differences in neurodevelopmental and psychiatric genetic risk in anxiety and depression.
    Martin J; Asjadi K; Hubbard L; Kendall K; Pardiñas AF; Jermy B; Lewis CM; Baune BT; Boomsma DI; Hamilton SP; Lucae S; Magnusson PK; Martin NG; McIntosh AM; Mehta D; Mors O; Mullins N; Penninx BWJH; Preisig M; Rietschel M; Jones I; Walters JTR; Rice F; Thapar A; O'Donovan M;
    PLoS One; 2021; 16(9):e0248254. PubMed ID: 34473692
    [TBL] [Abstract][Full Text] [Related]  

  • 58. De novo variants in TCF7L2 are associated with a syndromic neurodevelopmental disorder.
    Dias C; Pfundt R; Kleefstra T; Shuurs-Hoeijmakers J; Boon EMJ; van Hagen JM; Zwijnenburg P; Weiss MM; Keren B; Mignot C; Isapof A; Weiss K; Hershkovitz T; Iascone M; Maitz S; Feichtinger RG; Kotzot D; Mayr JA; Ben-Omran T; Mahmoud L; Pais LS; Walsh CA; Shashi V; Sullivan JA; Stong N; Lecoquierre F; Guerrot AM; Charollais A; Rodan LH
    Am J Med Genet A; 2021 Aug; 185(8):2384-2390. PubMed ID: 34003604
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 9q34.3 microduplications lead to neurodevelopmental disorders through EHMT1 overexpression.
    Bonati MT; Castronovo C; Sironi A; Zimbalatti D; Bestetti I; Crippa M; Novelli A; Loddo S; Dentici ML; Taylor J; Devillard F; Larizza L; Finelli P
    Neurogenetics; 2019 Aug; 20(3):145-154. PubMed ID: 31209758
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gain and loss of function variants in EZH1 disrupt neurogenesis and cause dominant and recessive neurodevelopmental disorders.
    Gracia-Diaz C; Zhou Y; Yang Q; Maroofian R; Espana-Bonilla P; Lee CH; Zhang S; Padilla N; Fueyo R; Waxman EA; Lei S; Otrimski G; Li D; Sheppard SE; Mark P; Harr MH; Hakonarson H; Rodan L; Jackson A; Vasudevan P; Powel C; Mohammed S; Maddirevula S; Alzaidan H; Faqeih EA; Efthymiou S; Turchetti V; Rahman F; Maqbool S; Salpietro V; Ibrahim SH; di Rosa G; Houlden H; Alharbi MN; Al-Sannaa NA; Bauer P; Zifarelli G; Estaras C; Hurst ACE; Thompson ML; Chassevent A; Smith-Hicks CL; de la Cruz X; Holtz AM; Elloumi HZ; Hajianpour MJ; Rieubland C; Braun D; Banka S; ; French DL; Heller EA; Saade M; Song H; Ming GL; Alkuraya FS; Agrawal PB; Reinberg D; Bhoj EJ; Martínez-Balbás MA; Akizu N
    Nat Commun; 2023 Jul; 14(1):4109. PubMed ID: 37433783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.